Neoadjuvant chemotherapy for obstructive colon cancer after stent
Treatments studied
Part of Cancer, Digestive system, Injuries & trauma clinical trials.
This trial studies whether chemotherapy given before surgery works better for people with colon cancer that is blocking the bowel. To join, you typically need a colon stent placed to relieve the blockage within 48 hours and meet several health and lab safety checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 20 to under 75 years old
- You have stage II or III colon cancer causing a bowel blockage, confirmed by tests and pathology
- Your tumor is in the lower colon (between the descending/upper rectosigmoid area), more than 15 cm from the anus
- A colonoscopy shows the tumor blocks the whole circumference and you couldn’t pass the scope through it
- You must have a SEMS (colon stent) placed, with successful decompression within 48 hours and no stent-related injury
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving chemotherapy before surgery helps people with colon cancer that caused a blockage and needed a temporary colostomy. It aims to improve outcomes compared to standard treatment.
This trial tests whether placing a stent first to relieve a blockage in the right side of the colon improves outcomes before surgery for colon cancer. It aims to help patients who come to the hospital with a blocked colon due to cancer.
This trial compares giving chemotherapy before surgery versus going straight to surgery for certain stage II/III colon cancers. It may help shrink the tumor and improve outcomes by testing which approach works best for high-risk cases.
This study compares emergency surgery to placing a stent first for people with a blocked colon from cancer. It also looks at whether a special recovery program (ERAS) helps you heal faster after surgery.
This trial tests whether giving chemotherapy before surgery can improve outcomes for people with colon cancer that has grown into nearby tissue or lymph nodes but hasn't spread to other organs. It is for patients whose tumors are mismatch repair proficient (pMMR) or microsatellite stable (MSS).
This Phase 2 trial studies giving chemotherapy plus immune therapy before surgery for certain colon cancers that do not have mismatch repair defects (MSS/pMMR). The goal is to shrink and control the tumor and improve outcomes compared with standard approaches.
Hear when a new Colon Cancer, Obstruction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.